5篇
您的检索式：作者名="Diamandopoulos"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Substitution of renal function through skin catharsis:evidence from the classical period to the middle ages显示文摘 | Diamandopoulos AA Goudas PC | 2001 | Kidney Int2001，59，： | 1 |
| 2 | Acute renal failure according to ancient Greek and Byzantine medical writem显示文摘 | Marketos SG Efiychiadis AG Diamandopoulos A | 1993 | JR Soc Med1993，，86： | 1 |
| 3 | Comparison of estimated creatinine clearance among five formulae (Cockroft-Gault,Jelliffe,Sanaka,simplified 4-variable MDRD and DAF) and the 24hours-urine-collection creatinine clearance显示文摘 | Diamandopoulos A Goudas P Arvanitis A | | 0，，02： | 1 |
| 4 | Atrial Fibrillation Increases Production of Superoxide by the Left Atrium and Left Atrial Appendage: Role of the NADPH and Xanthine Oxidases显示文摘 | Samuel C. Dudley Nyssa E. Hoch Louise A. McCann Clegg Honeycutt Laura Diamandopoulos Tohru Fukai David G. Harrison Sergey I. Dikalov Jonathan Langberg | 2005 | Circulation2005，，9： | 1 |
| 5 | Emperor’s syndrome in the COVID-19 era:Time for patient-centered nephrology?显示文摘The coronavirus disease-19(COVID-19)pandemic has been a wake-up call in which has forced us to react worldwide.Health policies and practices have attracted particular attention in terms of human and financial cost.Before COVID-19,chronic kidney disease was already considered a risk multiplier in patients with diabetes and hypertension,the two now being the major risk factors for COVID-19 infection and adverse outcome.In contrast to the urgent need for action,the nephrology field is considered to be in a state of stagnation regarding the management of chronic kidney disease patients who still experience unacceptably high morbidity and mortality.Ironically and paradoxically in a field lacking robust clinical trials,clinical practice is driven by guidelines-based medicine on weak evidence.The Emperor’s syndrome,referring to Hans Christian Andersen’s fairy tale,has been described in medicine as voluntary blindness to an obvious truth,being a weak evidence-based therapeutic intervention or weak health care.A promising positive example of improving heart and kidney outcomes is the emerging treatment with sodium-glucose cotransporter 2 inhibitors.COVID-19 could boost actions for patient-centered care as a positive shift in nephrology care. | Dimitra Bacharaki Athanasios Diamandopoulos | 2021 | World Journal of Nephrology2021，10，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员